MedTrace Logo

Spectroscopy in Functional Assessment of Peripheral Artery Disease (spectroAMI)

NCT03723473 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2024-04-25

No results posted yet for this study

Summary

To explore the reliability of P-31 MR spectroscopy mitochondrial function in patients with peripheral arterial occlusive disease.

Conditions

  • Arterial Occlusive Diseases

Interventions

DEVICE

Magnetic Resonance Imaging (MRI)

MRI (muscular volume and composition) and gated-P-31 magnetic resonance spectroscopy (MRS) with low-intensity ergometric exercise.

Sponsors & Collaborators

  • Dr MAYER Ronald A. Department of Physiology, Michigan State University

    collaborator UNKNOWN

  • Dr SLADE Jill M. Department of Osteopathic Manipulative Medicine, Michigan State University

    collaborator UNKNOWN

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • Pierre CROISILLE, PhD · CHU SAINT-ETIENNE

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-13
Primary Completion
2025-04-30
Completion
2025-04-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03723473 on ClinicalTrials.gov